CN1768769A - 克疣 - Google Patents
克疣 Download PDFInfo
- Publication number
- CN1768769A CN1768769A CN 200510010358 CN200510010358A CN1768769A CN 1768769 A CN1768769 A CN 1768769A CN 200510010358 CN200510010358 CN 200510010358 CN 200510010358 A CN200510010358 A CN 200510010358A CN 1768769 A CN1768769 A CN 1768769A
- Authority
- CN
- China
- Prior art keywords
- wart
- powder
- gram
- dawn
- duck
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010153 skin papilloma Diseases 0.000 title claims abstract description 25
- 208000000260 Warts Diseases 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 10
- HBGOLJKPSFNJSD-UHFFFAOYSA-N Etamsylate Chemical compound CC[NH2+]CC.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 HBGOLJKPSFNJSD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000272525 Anas platyrhynchos Species 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 6
- 229960004817 etamsylate Drugs 0.000 claims description 6
- 229960004194 lidocaine Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 3
- 241000208225 Rhus Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 7
- 206010059313 Anogenital warts Diseases 0.000 description 4
- 241000934136 Verruca Species 0.000 description 4
- 201000004196 common wart Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 241001517488 Clavus Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
克疣属于医用药品；克疣由重量比占10％的鸭旦子油、1％的利多卡因粉、1％的止血敏粉和88％的医用乙醇配伍构成；将鸭旦子油脱壳、榨油，将鸭旦子油与利多卡因粉、止血敏粉和医用乙醇一并均匀混合得到克疣液体制剂；本发明治疗尖锐湿疣、扁平疣、寻常疣、鸡眼、手钉等病患具有疗程短、疗效好、无任何副作用、价格低廉、使用方便、适应范围广的特点。
Description
技术领域
本发明属于医用药品，主要涉及一种治疗扁平疣、寻常疣、尖锐湿疣等疾病的药品。
背景技术
目前，用于治疗扁平疣、寻常疣、尖锐湿疣等疣类疾病的口服和注射药物较多，在缓解病痛方面起到一定积极作用，但是，这些药物不仅价格较贵，而且在治疗过程中疗程长，长达数月至数年，不能彻底治愈，复发率高，对患者身体脏器副作用大。手术或激光治疗也是当前常用手段，但治疗后除易复发外，还极易在手术部位留有疤痕，甚至导致局部变形和畸形，给患者带来极大精神伤害。
发明内容
本发明的目的就是针对上述已有技术存在的问题和缺陷，研究一种能有效治疗疣类疾病的克疣，达到治疗效果好、疗程短、价格低廉、使用简单易行的目的。
本发明的目的是这样实现的：克疣由中药材的鸭旦子油与利多卡因粉、止血敏粉和酒精浓度95％的医用乙醇配伍组成，按其重量各成份所占比例分别为：鸭旦子油10％、利多卡因粉1％、止血敏粉1％、医用乙醇88％。
本发明的克疣适用于病毒感染引起的尖锐湿疣、扁平疣、寻常疣、鸡眼、手钉，也可用于治疗阿米巴痢疾、结肠癌的治疗，能在短时间内将各种病毒性疣体内病毒灭活，对阿米巴原虫及结肠癌有一定疗效，具有疗程短、疗效好、不复发、无痛、不出血、不留疤痕、无畸形、无需住院、治疗使用简易方便、不用任何辅助药物、价格低廉、适应范围广的特点。
具体实施方式
下面举实例进行详细说明。
首先将中药材鸭旦子油用脱壳机脱壳，再用榨油机榨取鸭旦子油。分别称取鸭旦子油100克、利多卡因粉10克、止血敏粉10克、酒精浓度95％的医用乙醇880克备用，其各成份按重量所占比例依次为10％、1％、1％和88％，总计100％；将100克鸭旦子油与10克利多卡因粉、10克止血敏粉及880克医用乙醇一并均匀混合得到呈金黄色、乙醇味且微苦的克疣液体制剂，将液体克疣装入无菌干燥的玻璃器皿中备用。
治疗使用时，根据疣体大小，在疣体基底部局部封闭注射克疣0.1-0.2毫升即可，也可以采用挂线治疗方法。在治疗中，除局部发红和微痛感外，无任何其他不良反应。临床实验中，用克疣治疗扁平疣、寻常疣患者198例，尖锐湿疣患者6例，鸡眼患者12例，均为一次性7天内全部治愈，且无一例复发。本药品不可口服和做静脉或肌肉注射使用。
Claims (1)
1、一种克疣，其特征在于该克疣由中药材的鸭旦子油与利多卡因粉、止血敏粉和酒精浓度95％的医用乙醇配伍组成，按其重量各成份所占比例分别为：鸭旦子油10％、利多卡因粉1％、止血敏粉1％、医用乙醇88％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010358 CN1768769A (zh) | 2005-09-22 | 2005-09-22 | 克疣 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510010358 CN1768769A (zh) | 2005-09-22 | 2005-09-22 | 克疣 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1768769A true CN1768769A (zh) | 2006-05-10 |
Family
ID=36750474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510010358 Pending CN1768769A (zh) | 2005-09-22 | 2005-09-22 | 克疣 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1768769A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008020037A1 (en) * | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| ES2315119A1 (es) * | 2006-08-16 | 2009-03-16 | Action Medicines, S.L. | Uso de derivados 2,5 -dihidrocibencenicos en la fabricacion de medicamentos y cosmeticos. |
-
2005
- 2005-09-22 CN CN 200510010358 patent/CN1768769A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008020037A1 (en) * | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| ES2315119A1 (es) * | 2006-08-16 | 2009-03-16 | Action Medicines, S.L. | Uso de derivados 2,5 -dihidrocibencenicos en la fabricacion de medicamentos y cosmeticos. |
| ES2315119B1 (es) * | 2006-08-16 | 2009-12-30 | Action Medicines, S.L. | Uso de derivados 2,5 -dihidroxibencenicos en la fabricacion de medicamentos y cosmeticos. |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210008239A1 (en) | Medical Ozone Sterile Isotonic Saline Solution And Preparation Method And Application Thereof | |
| US20040180868A1 (en) | Composition and method for treating inflammations by reducing C-reactive protein | |
| CN1768769A (zh) | 克疣 | |
| CN102302559B (zh) | 一种呼吸系统疾病药及其应用 | |
| CN102343006A (zh) | 一种治疗烧烫伤的药膏及制备方法 | |
| CN102078472A (zh) | 一种治疗疣赘的药剂 | |
| CN1488368A (zh) | 鼻炎清 | |
| CN100556440C (zh) | 一种治疗糖尿病的中药药物组合物及其制备方法和应用 | |
| Mavrakakis | IgE-Mediated Cytokine Storm in Vaccinated Populations: Call for Further Investigation and Caution | |
| CN100998604B (zh) | 一种治疗烧伤烫伤的中药及其制备方法 | |
| CN102988403A (zh) | 用于治疗急性期面瘫的注射药物组合 | |
| CN101837016B (zh) | 一种治疗外伤的中药制剂 | |
| Lockhart | (834): Topical sterile lidocaine patch to reduce postoperative pain and decrease need for oral analgesics after inguinal herniorrhaphy | |
| CN1273161C (zh) | 一种治疗急性乳腺炎的口服液 | |
| Tymofieieva et al. | Usage of the Medical Product Ketanov in the Maxillofacial Surgery | |
| CN100998659A (zh) | 一种治疗外伤的外用中药 | |
| CN106822234A (zh) | 一种治疗高血压的中西药组合物及其制备方法 | |
| CN107029189A (zh) | 治疗冠心病的中药 | |
| CN101972296A (zh) | 一种治疗面瘫的外敷中药 | |
| CN1868465A (zh) | 蒽醌类衍生物（大黄素）在制药中的应用 | |
| CN104800241B (zh) | 富氧联合用药医疗技术 | |
| CN106619975A (zh) | 一种用于治疗糖尿病足的足三里穴位注射用药物及其制法 | |
| CN119700946A (zh) | Ryk-Fc融合蛋白在制备抗癌性疼痛药物中的应用 | |
| CN102784201B (zh) | 一种治疗结块无头型暑疖的糊状药物 | |
| CN1147958A (zh) | 一种治疗外伤疾病的药品组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |